Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-17-371184
Filing Date
2017-12-18
Accepted
2017-12-18 06:11:17
Documents
8
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 20-F/A d498571d20fa.htm 20-F/A 28238
2 EX-4.11 d498571dex411.htm EX-4.11 591698
3 EX-4.13 d498571dex413.htm EX-4.13 580316
4 EX-4.14 d498571dex414.htm EX-4.14 639521
5 EX-12.1 d498571dex121.htm EX-12.1 2986
6 EX-12.2 d498571dex122.htm EX-12.2 3009
7 GRAPHIC g498571g1019070953179.jpg GRAPHIC 8770
8 GRAPHIC g498571g1019070953257.jpg GRAPHIC 2151
  Complete submission text file 0001193125-17-371184.txt   1862206
Mailing Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077
Business Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: 20-F/A | Act: 34 | File No.: 000-29962 | Film No.: 171260271
SIC: 2834 Pharmaceutical Preparations